Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes

PURPOSE: Local ablative treatment (LAT) is increasingly combined with systemic therapy in oligometastatic breast cancer (OMBC), without a high-level evidence to support this strategy. We evaluated the addition of LAT to systemic treatment in terms of progression-free survival (PFS) and overall survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Glemarec, Gauthier, Lacaze, Jean-Louis, Cabarrou, Bastien, Aziza, Richard, Jouve, Eva, Zerdoud, Slimane, De Maio, Eleonora, Massabeau, Carole, Loo, Maxime, Esteyrie, Vincent, Ung, Mony, Dalenc, Florence, Izar, Francoise, Chira, Ciprian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982270/
https://www.ncbi.nlm.nih.gov/pubmed/36709639
http://dx.doi.org/10.1016/j.breast.2022.12.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982270/
https://www.ncbi.nlm.nih.gov/pubmed/36709639
http://dx.doi.org/10.1016/j.breast.2022.12.035

Ejemplares similares